Resumen de acción JYNT
The Joint Corp. explota y franquicia clínicas quiroprácticas en Estados Unidos.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de The Joint Corp.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.06 |
| 52 Week High | US$17.07 |
| 52 Week Low | US$7.31 |
| Beta | 1.58 |
| 1 Month Change | 40.41% |
| 3 Month Change | 70.60% |
| 1 Year Change | 20.91% |
| 3 Year Change | -67.87% |
| 5 Year Change | -2.29% |
| Change since IPO | 159.27% |
Noticias y actualizaciones recientes
Recent updates
Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking
May 04
The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up
Mar 10Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Feb 12Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Jun 17Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher
Jan 04Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?
Oct 27The Joint Corp. Can Relieve You From High Inflation Pain
Oct 17The Joint Corp.: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape
Aug 05These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well
Jul 22Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Jun 29Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?
Jun 14Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Mar 03Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?
Feb 23Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?
Feb 08Joint Corp.: Solid Q4 Results From This Small-Cap Growth Story
Jan 30Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Jan 24What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate?
Jan 08Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?
Nov 23Is Joint (NASDAQ:JYNT) A Risky Investment?
Nov 08Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Oct 21Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?
Oct 05The Joint Corporation: Time To Take Some Profits
Aug 10Is Joint (NASDAQ:JYNT) Using Too Much Debt?
Aug 02The Joint Corp. Has Rallied By 400% Since We Bought, But It's Time To Let It Go
Jul 23Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Jul 15Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?
Jun 04Rentabilidad de los accionistas
| JYNT | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | 5.8% | 1.6% | 1.0% |
| 1Y | 20.9% | 6.1% | 27.2% |
Rentabilidad vs. Industria: JYNT superó a la industria US Healthcare, que obtuvo un rendimiento del 2.1% el año pasado.
Rentabilidad vs. Mercado: JYNT obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| JYNT volatility | |
|---|---|
| JYNT Average Weekly Movement | 13.0% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.9% |
Precio estable de las acciones: El precio de las acciones de JYNT ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de JYNT(11%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de US.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2010 | 619 | Peter Holt | www.thejoint.com |
The Joint Corp. explota y franquicia clínicas quiroprácticas en Estados Unidos. La empresa opera en dos segmentos, Clínicas Corporativas y Operaciones de Franquicia. The Joint Corp. se constituyó en 2010 y tiene su sede en Scottsdale, Arizona.
Resumen de fundamentos de The Joint Corp.
| Estadísticas fundamentales de JYNT | |
|---|---|
| Capitalización bursátil | US$246.32m |
| Beneficios(TTM) | -US$11.13m |
| Ingresos (TTM) | US$119.12m |
2.1x
Ratio precio-ventas (PS)-22.9x
Ratio precio-beneficio (PE)¿Está JYNT sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de JYNT | |
|---|---|
| Ingresos | US$119.12m |
| Coste de los ingresos | US$10.79m |
| Beneficio bruto | US$108.33m |
| Otros gastos | US$119.46m |
| Beneficios | -US$11.13m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.74 |
| Margen bruto | 90.94% |
| Margen de beneficio neto | -9.34% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado JYNT a largo plazo?
Ver rendimiento histórico y comparativa